Research Article| Volume 30, ISSUE 2, P299-310, February 1999

Rapid clearance of transplanted hepatocytes from pulmonary capillaries in rats indicates a wide safety margin of liver repopulation and the potential of using surrogate albumin particles for safety analysis


      Background/Aims: Applications of liver repopulation by hepatocyte transplantation require analysis of cell biodistributions, particularly when portasystemic shunting coexists. The aims of this study were to determine the fate of hepatocytes transplanted into the pulmonary vascular bed and to examine whether cell biodistributions could be approximated by convenient surrogates.
      Methods: Rat hepatocytes and macroaggregated serum albumin particles of similar sizes were injected into the portal and pulmonary vascular beds of rats, followed by biodistribution, survival and function analyses.
      Results: Although functionally intact, virtually all hepatocyteswere cleared from the pulmonary capillaries within 24 h. Serum albumin levels increased minimally in Nagase analbuminemic rats with or without portacaval shunting to enhance delivery of portal factors to transplanted cells in lungs. Despite intravenous injection of hepatocytes approaching >1×109 cells in humans, the hemodynamic changes were limited to transient increases in right atrial pressures. The hepatocyte distributions in specific vascular beds were largely reproduced by macroaggregated human serum albumin particles.
      Conclusions: Incidental intrapulmonary cell translocations during liver repopulation will have a wide safety margin. Use of macroaggregated serum albumin particles as surrogates for initial short-term biodistribution and safety analysis will advance hepatocyte transplantation, as the cost of GLP-certified laboratories and consumption of scarce donor livers will be avoided.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gupta S
        • Rajvanshi P
        • Bhargava KK
        • Kerr A
        Hepatocyte transplantation: progressing toward liver repopulation.
        in: Boyer JL Ockner RL Progress in Liver Diseases, Vol. 14. WB Saunders, Philadelphia1996: 199-222
        • Gupta S
        • Roy Chowdhury N
        • Jagtiani R
        • Gustin K
        • Shafritz DA
        • Roy Chowdhury J
        • et al.
        A novel system for transplantation of isolated hepatocytes utilizing HBsAg producing transgenic donor cells.
        Transplantation. 1990; 50: 472-475
        • Gupta S
        • Aragona E
        • Vemuru RP
        • Bhargava K
        • Burk RD
        • Roy Chowdhury J
        Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation.
        Hepatology. 1991; 14: 144-149
        • Ponder KP
        • Gupta S
        • Leland F
        • Darlington G
        • Finegold M
        • De-Mayo J
        • et al.
        Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation.
        Proc Natl Acad Sci USA. 1991; 88: 1217-1221
        • Gupta S
        • Rajvanshi P
        • Lee C-D
        Integration of transplanted hepatocytes in host liver plates demonstrated with dipeptidyl peptidase IV deficient rats.
        Proc Natl Acad Sci USA. 1995; 92: 5860-5864
        • Gupta S
        • Vemuru RP
        • Lee C-D
        • Yerneni P
        • Aragona E
        • Burk RD
        Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: implications for hepatic gene therapy.
        Hum Gene Ther. 1994; 5: 959-967
        • Rajvanshi P
        • Kerr A
        • Bhargava KK
        • Burk RD
        • Gupta S
        Studies of liver repopulation using the dipeptidyl peptidase IV deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule.
        Hepatology. 1996; 23: 482-496
        • Rajvanshi P
        • Kerr A
        • Bhargava KK
        • Burk RD
        • Gupta S
        Studies in rodents to demonstrate efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation.
        Gastroenterology. 1996; 111: 1092-1102
        • Gupta S
        • Yerneni P
        • Vemuru RP
        • Lee CD
        • Yellin EL
        • Bhargava KK
        Studies on the safety of intrasplenic hepatocyte transplantation: relevance to ex-vivo gene therapy and liver repopulation in acute hepatic failure.
        Hum Gene Ther. 1993; 4: 249-257
        • Selden AC
        • Gupta S
        • Johnstone R
        • Hodgson HJF
        The pulmonary vascular bed as a site for implantation of isolated liver cells in inbred rats.
        Transplantation. 1984; 38: 81-83
        • Sandbichler P
        • Then P
        • Vogel W
        • Erhart R
        • Dictze O
        • Philadelphy H
        • et al.
        Hepatocellular transplantation into the lung for temporary support of acute liver failure in the rat.
        Gastroenterology. 1992; 102: 605-609
        • Sandbichler P
        • Erhart R
        • Herbst P
        • Vogel W
        • Herold M
        • Dietze O
        • et al.
        Hepatocellular transplantation into the lung in chronic liver failure following bile duct obstruction in the rat.
        Cell Transplant. 1994; 3: 409-412
        • Fabrega AJ
        • Bommineni VR
        • Blanchard J
        • Tetali S
        • Rivas PA
        • Pollak R
        • et al.
        Amelioration of analbuminemia by transplantation of allogeneic hepatocytes in tolerized rats.
        Transplantation. 1995; 59: 1362-1364
        • Gupta S
        • Vasa SRG
        • Rajvanshi P
        • Zuckier L
        • Palestro CJ
        • Bhargava KK
        Analysis of hepatocyte distribution and survival in vascular beds with cells marked by 99mTc or endogenous dipeptidyl peptidase IV activity.
        Cell Transplant. 1997; 6: 377-386
        • Rajvanshi P
        • Bhargava KK
        • Afriye M
        • Camaya M
        • Gagandeep S
        • Vasa SRG
        • et al.
        Human serum albumin microspheres approximate initial organ-specific biodistributions of transplanted hepatocytes and are effective cell surrogates for safety studies.
        Cell Transplant. 1998; 7: 275-283
        • Lee SH
        • Fisher B
        Portacaval shunt in the rat.
        Surgery. 1961; 50: 668-672
        • Bensley CM
        Comparison of methods for demonstrating glycogen microscopically.
        Stain Technol. 1930; 14: 47-52
        • Haggart GE
        • Walker AM
        The physiology of pulmonary embolism as disclosed by quantitative occlusion of the pulmonary artery.
        Arch Surg. 1923; 6: 764-783
        • Ostensen J
        • Hede R
        • Myreng Y
        • Ege T
        • Holtze E
        Intravenous injection of Albunex microspheres causes thromboxane mediated pulmonary hypertension in pigs, but not in monkeys or rabbits.
        Acta Physiol Scand. 1992; 144: 307-315
        • Feinstein SB
        • Cheirif J
        • Ten Cate FJ
        • Silverman PR
        • Heidenreich PA
        • Dick C
        • et al.
        Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter results.
        J Am Coll Cardiol. 1990; 16: 316-324
        • Ten Cate FJ
        • Widisky P
        • Cornel JH
        • Waldstein DJ
        • Serruys PW
        • Waaler A
        Intracoronary Albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans.
        Circulation. 1993; 88: 2123-2127
        • Okuda K
        • Suzuki K
        • Musha H
        • Arimuzu N
        Percutaneous transhepatic catheterization of the portal vein for the study of portal hemodynamics and shunts. A preliminary report.
        Gastroenterology. 1977; 73: 279-284
        • Ohnishi K
        • Chin N
        • Saito M
        • Tanaka H
        • Terabayashi H
        • Nakayama T
        • et al.
        Portographic opacification of hepatic veins and (anomalous) anastomoses between the portal and hepatic veins in cirrhosis: indication of extensive intrahepatic shunts.
        Am J Gastroenterol. 1986; 81: 975-978
        • Ohnishi K
        • Saito M
        • Sato S
        • Terabayashi H
        • Iida S
        • Nomura F
        • et al.
        Portal hemodynamics in idiopathic portal hypertension (Banti's syndrome). Comparison with chronic persistent hepatitis and normal subjects.
        Gastroenterology. 1987; 92: 751-758
        • Ohnishi K
        • Chin N
        • Sugita S
        • Saito M
        • Tanaka H
        • Terabayashi H
        • et al.
        Quantitative aspects of portal-systemic and arteriovenous shunts within the liver in cirrhosis.
        Gastroenterology. 1987; 93: 129-134
        • Nomura F
        • Ohnishi K
        • Terabayashi H
        • Nakai T
        • Isobe K
        • Takekoshi K
        • et al.
        Effect of intrahepatic portal-systemic shunting on hepatic ammonia extraction in patients with cirrhosis.
        Hepatology. 1994; 20: 1478-1481
        • Chin N
        • Ohnishi K
        • Iida S
        • Nomura F
        Role of intrahepatic portal-systemic shunts in the reduction of portal blood supply to liver cells in cirrhosis.
        Am J Gastroenterol. 1988; 83: 718-722
        • Walser EM
        • Harris VM
        • Harman JT
        • Park HM
        • Siddiqui AR
        Quantification of intrahepatic portosystemic shunting after placement of a transjugular intrahepatic portosystemic shunt.
        J Vasc Intervent Radiol. 1996; 7: 263-267
        • Hoefs JC
        • Rcynolds TB
        • Pare P
        • Sakimura I
        A new method for the measurement of intrahepatic shunts.
        J Clin Lab Med. 1984; 103: 446-461
        • Bledin AG
        • Kantarjian HM
        • Kim EE
        • Wallace S
        • Chuang VP
        • Patt YZ
        • et al.
        99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy.
        Am J Roentgenol. 1982; 139: 711-715
        • Kaplan WD
        • Come SE
        • Takvorian RW
        • Laffin SM
        • Gelman RS
        • Weiss GR
        • et al.
        Pulmonary uptake of technetium 99m macroag-gregated albumin: a predictor of gastrointestinal toxicity during hepatic artery perfusion.
        J Clin Oncol. 1984; 2: 1266-1269
        • Sigurdson ER
        • Ridge JA
        • Kemeny N
        • Daly JM
        Tumor and liver drug uptake following hepatic artery and portal vein infusion.
        J Clin Oncol. 1987; 5: 1836-1840
        • Leung TW
        • Lau WY
        • Ho SK
        • Chan M
        • Leung NW
        • Lin J
        • et al.
        Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma.
        Cancer Chemother Pharmacol. 1994; 33: S33-S36
        • Nagai T
        • Jimbo M
        • Sano K
        Cerebro-pulmonary scan using macroaggregated albumin as a quantitation of intracerebral arteriovenous shunting.
        J Nucl Med. 1967; 8: 709-722
        • Taplin GV
        • Jhonson DE
        • Kennady JC
        • Dore EK
        • Poe ND
        • Swanson LA
        • et al.
        Aggregated albumin labeled with various radioisotopes, radioactive pharmaceuticals.
        US-AEC, CONF-65. 1966; 1111: 525
        • Hamilton GW
        • Ritchie JL
        • Allen D
        • Lapin E
        • Murray JA
        Myocardial perfusion imaging with 99mTc or 113m In macroaggregated albumin: correlation of the perfusion image with clinical, angiographic, surgical, and histologic findings.
        Am Heart J. 1975; 89: 708-715
        • Feiring AJ
        • Bruch P
        • Husayni TS
        • Kirchner PT
        • Marcus ML
        Premortem assessment of myocardial area at risk with the use of intracoronary technetium macroaggregated albumin and gated nuclear imaging.
        Circulation. 1986; 73: 551-561
        • Walday P
        • Tolleshaug H
        • Gjoen T
        • Kindberg GM
        • Berg T
        • Skotland T
        • et al.
        Biodistributions of air-filled albumin microspheres in rats and pigs.
        Biochem J. 1994; 299: 437-443